FindMyKOL

Kevin Nusz, MD

Basic profile

Ophthalmology

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionLancaster, SC · SoutheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLFindMyKOL type: RegionalLatest publication2010Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Kevin Nusz is an Ophthalmology physician. OpenAlex indexes 9 publications with 517 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
9publications

Publications indexed by OpenAlex. Counts exclude supporting files.

517citations

Citations across these publications.

6h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Alcon Vision LLC
    Program year202515 payments
    $683
  • Astellas Pharma US Inc
    Program year20257 payments
    $257
  • ABBVIE INC.
    Program year20259 payments
    $181
All 32 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    82.5%
    Prostaglandin Analog27.6%
    Latanoprost94%Lumigan6%
    Part D<11 patients
    Corticosteroid13.1%
    Prednisolone Acetate100%
    Part D≥135 patients

    + 7 more classes in this area

  • Musculoskeletal

    9.7%
    Cyclooxygenase Inhibitor9.7%
    Ketorolac Tromethamine100%
    Part D≥102 patients
  • Anti-infectives

    4.3%
    Tetracycline-class Drug2.8%
    Doxycycline Monohydrate53%Doxycycline Hyclate47%
    Part D≥25 patients
    Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor1.5%
    Valacyclovir100%
    Part D<11 patients
Where care is delivered (Part B)10.5% facility · 89.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”